Macasasa, Rogelio P.

HRN: 29-17-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CO-AMOXICLAV 625MG (TAB)
06/20/2026
06/26/2026
ORAL
625mg
Tid
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: